References of "Van Steen, Kristel"
     in
Bookmark and Share    
Full Text
Peer Reviewed
See detailLong-term outcome after infliximab for refractory ulcerative colitis
Ferrante, M.; Vermeire, S.; Fidder, H. et al

in Journal of Crohn’s and Colitis [=JCC] (2008), 2(3), 219-225

Background and aims: Infliximab (IFX) has been shown efficacious for moderate-to-severe ulcerative colitis (UC), but data on long-term efficacy are tacking. We investigated long-term outcome including ... [more ▼]

Background and aims: Infliximab (IFX) has been shown efficacious for moderate-to-severe ulcerative colitis (UC), but data on long-term efficacy are tacking. We investigated long-term outcome including colectomy rates in outpatients treated with IFX for refractory UC in a single referral centre, and evaluated if predictors could be identified. Methods: The first 121 outpatients (median age 38.0 years) with refractory UC treated with IFX were included. The primary outcome was colectomy-free survival. Secondary measures were sustained clinical response and serious adverse events. Results: From the 81 patients (67%) with an initial clinical response to IFX, 68% had a sustained clinical response. No independent predictors of sustained clinical response could be identified. Over a median (IQR) follow-up period of 33.0 (17.0-49.8) months, 21 patients (17%) came to colectomy. Independent predictors of colectomy were absence of short-term clinical response [Hazard ratio 10.8 (95% Cl 3.5-32.8), p < 0.001], a baseline CRP level >= 5 mg/L [Hazard ratio 14.5 (95% Cl 2.0-108.6), p=0.006] and previous IV treatment with corticosteroids and/or cyctosporine [Hazard ratio 2.4 (95% Cl 1.1-5.9), p=0.033]. Six patients developed a serious infection, three a malignancy, two a post-operative complication and one patient died (suicide). Conclusions: With a median follow-upof 33.0 months after start of IFX, 17% of patients with refractory UC needed colectomy, while sustained clinical response was present in 68% of initial responders. (c) 2008 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved. [less ▲]

Detailed reference viewed: 83 (4 ULg)
Full Text
Peer Reviewed
See detailStability of gut microbiota over time in Crohn's disease patients compared to healthy relatives
Joossens, M.; De Preter, V.; Van Steen, Kristel ULg et al

in Gastroenterology (2008), 134(4), 653-653

Detailed reference viewed: 27 (8 ULg)
Full Text
Peer Reviewed
See detailMucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease
Arijs, I.; Van Lommel, L.; Van Steen, Kristel ULg et al

in Journal of Crohn’s and Colitis [=JCC] (2008), 2(1), 64

Detailed reference viewed: 10 (2 ULg)
Full Text
Peer Reviewed
See detailImproving strategies for detecting genetic patterns of disease susceptibility in association studies
Calle, M. L.; Urrea, V.; Malats, N. et al

in Statistics in Medicine (2008), 27(30), 6532-6546

Detailed reference viewed: 41 (7 ULg)
Full Text
Peer Reviewed
See detailA Family-based Association Test for Quantitative Traits to Detect Gene-Gene Interactions
De Lobel, L.; De Meyer, H.; Thijs, L. et al

in Genetic Epidemiology (2008), 32(7), 686-686

Detailed reference viewed: 18 (6 ULg)
Full Text
Peer Reviewed
See detailHeritability of blood concentrations of sex-steroids in relation to body composition in young adult male siblings.
Bogaert, Veerle; Taes, Youri; Konings, Peter et al

in Clinical Endocrinology (2008), 69(1), 129-35

OBJECTIVE: Sex steroid concentrations in men are related to body composition and both are determined by genetic and environmental factors. This study investigates heritability estimates of sex steroid ... [more ▼]

OBJECTIVE: Sex steroid concentrations in men are related to body composition and both are determined by genetic and environmental factors. This study investigates heritability estimates of sex steroid serum concentrations and body composition as well as the genetic and environmental components of their interrelation. PATIENTS: Six hundred and seventy-four men (25-45 years) were included in this study with 274 independent pairs of brothers. MEASUREMENTS: Body composition and regional fat mass estimates were determined using dual-energy X-ray absorptiometry. Serum testosterone (T), SHBG, oestradiol (E(2)) and LH levels were determined by immunoassay; free T and E(2) levels were calculated. RESULTS: Both sex steroid hormone concentrations and indices of body composition exhibited significant heritability estimates. Among sex steroid hormones, T had the highest heritability (h(2) = 0.65), followed by free T (h(2) = 0.54). A heritability of 0.73 was observed for SHBG; a heritability estimate of 0.83 was obtained for body weight. Significant genetic correlations were found between whole body fat mass and serum T (rho(G) = -0.46), free T (rho(G) = -0.27) and SHBG (rho(G) = -0.48) concentrations. No genetic relationship was observed between total (F) E(2) or LH concentrations, respectively, and body composition. CONCLUSION: Both sex steroid serum levels and body composition are under strong genetic control. Their interrelation is in part underlied by a genetic correlation, indicative of the action of shared genes. [less ▲]

Detailed reference viewed: 38 (4 ULg)
Full Text
Peer Reviewed
See detailDevelopment of psoriasiform skin lesions under anti-TNF therapy: a genetic link?
Cleynen, I.; Claes, B.; Nuytten, H. et al

in Conference Abstract Book (2008)

Detailed reference viewed: 23 (3 ULg)
Full Text
Peer Reviewed
See detailGenetic markers and the risk of complicated disease behaviour in Crohn's disease patients
Henckaerts, L.; Cleynen, I.; Joossens, M. et al

in Gastroenterology (2008), 134(4), 349-349

Detailed reference viewed: 19 (4 ULg)
Full Text
Peer Reviewed
See detailMucosal gene signatures to predict response to infliximab in patients with inflammatory bowel disease.
Arijs, I.; Van Lommel, L.; Van Steen, Kristel ULg et al

in Gastroenterology (2008), 134

Detailed reference viewed: 17 (11 ULg)
Full Text
Peer Reviewed
See detailEffect of infliximab treatment on colonic mucosal gene expression profiles in patients with inflammatory bowel disease
Arijs, I.; Quintens, R.; Van Lommel, L. et al

in Gut (2008), 57(Suppl II), 39

Detailed reference viewed: 9 (3 ULg)
Full Text
Peer Reviewed
See detailMicroarray study of mucosal antimicrobial peptides in patients with inflammatory bowel disease before and after infliximab treatment.
Arijs, I.; Van Lommel, L.; Van Steen, Kristel ULg et al

in Journal of Crohn’s and Colitis [=JCC] (2008), 2(1), 60

Detailed reference viewed: 19 (6 ULg)
Full Text
Peer Reviewed
See detailTNFA-3086 > A in two international population-based cohorts and risk of asthma
Castro-Giner, F.; Kogevinas, M.; Maechler, M. et al

in European Respiratory Journal (2008), 32(2), 350-361

Genetic association studies have related the tumour necrosis factor-a gene (TNFA) guanine to adenine substitution of nucleotide -308 (-3086 > A) polymorphism to increased risk of asthma, but results are ... [more ▼]

Genetic association studies have related the tumour necrosis factor-a gene (TNFA) guanine to adenine substitution of nucleotide -308 (-3086 > A) polymorphism to increased risk of asthma, but results are inconsistent. The aim of the present study was to test whether two single-nucleotide polymorphisms, of TNFA and of the lymphotoxin-alpha gene (LTA), are associated with asthma, bronchial hyperresponsiveness and atopy in adults, by combining the results of two large population-based multicentric studies and conducting a meta-analysis of previously published studies. The European Community Respiratory Health Survey (ECRHS) and Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in Adults (SAPALDIA) used comparable protocols, including questionnaires for respiratory symptoms and measures of lung function and atopy. DNA samples from 11,136 participants were genotyped at TNFA -308 and LTA 252. Logistic regression employing fixed and random effects models and nonparametric techniques were used. The prevalence of asthma was 6%. The TNFA -3086 > A polymorphism was associated with increased asthma prevalence and with bronchial hyperresponsiveness. No consistent association was found for atopy. The LTA 252A > G polymorphism was not associated with any of the outcomes. A meta-analysis of 17 studies showed an increased asthma risk for the TNFA -308 adenine allele. The tumour necrosis factor-alpha gene nucleotide -308 polymorphism is associated with a moderately increased risk of asthma and bronchial hyperresponsiveness, but not with atopy. These results are supported by a meta-analysis of previously published studies. [less ▲]

Detailed reference viewed: 35 (4 ULg)
Full Text
Peer Reviewed
See detailLong term stability of gut microbiota in Crohn’s disease patients compared to healthy relatives
Joossens, M.; De Preter, V.; Van Steen, Kristel ULg et al

in Acta Gastro-Enterologica Belgica (2008), 71

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailFAM-MDR: a flexible method of multifactor dimensionality reduction for high-order interaction detection
Van Steen, Kristel ULg; Calle, M.; Urrea, V. et al

in Conference Abstract book (2008)

Detailed reference viewed: 24 (6 ULg)
Full Text
Peer Reviewed
See detailAlternative methods to detect gene-gene interactions
De Lobel, L.; De Meyer, H.; Baele, G. et al

in Conference Abstract Book (2008)

Detailed reference viewed: 14 (5 ULg)
Full Text
Peer Reviewed
See detailFaecal bacterial dgge profiles of Crohn's disease patients are different from those of their healthy first degree relatives and matched healthy controls
Joossens, M.; Vanhoutte, T.; De Preter, V. et al

in Gastroenterology (2007), 132(4), 704-704

Detailed reference viewed: 25 (3 ULg)
Full Text
Peer Reviewed
See detailGene expression profiling to predict the response of infliximab in patients with UC
Arijs, Ingrid; Van lommel, Leertje; Van Steen, Kristel ULg et al

in Gastroenterology (2007), 132(4), 174-174

Detailed reference viewed: 13 (2 ULg)
Full Text
Peer Reviewed
See detailMixed IBD families: A distinct entity within IBD
Pierik, M.; Van Steen, Kristel ULg; Joossens, M. et al

in Gastroenterology (2007), 132(4), 450-450

Detailed reference viewed: 9 (4 ULg)
Full Text
Peer Reviewed
See detailGenetic markers and the risk of complicated disease behaviour in Crohn’s disease patients
Henckaerts, L.; Verstreken, I.; Van Steen, Kristel ULg et al

in Gut (2007)

Detailed reference viewed: 35 (0 ULg)